Will the use of anabolic androgenic steroids become a significant cardiovascular risk factor in the future?

Introduction and purpose: Cardiovascular diseases are the leading cause of mortality in many European countries. Major modifiable risk factors include dyslipidemia, hypertension, smoking and diabetes. The aim of our study is to draw attention to the possible impact of the use of anabolic androgenic...

Full description

Saved in:
Bibliographic Details
Main Authors: Piotr Pawłucki (Author), Anna Maciak (Author), Ewelina Andrasz (Author), Paulina Cuper (Author), Michał Sekuła (Author), Błażej Dziurowicz (Author)
Format: Book
Published: Kazimierz Wielki University, 2023-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_da2bc3b05828490d9ae179d9ba6eeec1
042 |a dc 
100 1 0 |a Piotr Pawłucki  |e author 
700 1 0 |a Anna Maciak  |e author 
700 1 0 |a Ewelina Andrasz  |e author 
700 1 0 |a Paulina Cuper  |e author 
700 1 0 |a Michał Sekuła  |e author 
700 1 0 |a Błażej Dziurowicz  |e author 
245 0 0 |a Will the use of anabolic androgenic steroids become a significant cardiovascular risk factor in the future? 
260 |b Kazimierz Wielki University,   |c 2023-08-01T00:00:00Z. 
500 |a 10.12775/JEHS.2023.45.01.019 
500 |a 2391-8306 
520 |a Introduction and purpose: Cardiovascular diseases are the leading cause of mortality in many European countries. Major modifiable risk factors include dyslipidemia, hypertension, smoking and diabetes. The aim of our study is to draw attention to the possible impact of the use of anabolic androgenic steroids on increased cardiovascular risk. Brief description of the state of knowledge: Currently, an increasing proportion of the population uses anabolic-androgenic steroids (AAS). This situation applies not only to athletes, but also to amateurs. The use of AAS may be associated with numerous complications. These include an increased risk of cardiovascular disease. The literature describes the effect of AAS use on the occurrence of dyslipidemia, insulin resistance, hypertension and metabolic syndrome. All these metabolic disorders result in increased cardiovascular risk. To prevent complications, it seems best to withdraw AAS gradually under medical supervision to minimize withdrawal effects. Conclusion: The use of AAS may cause cardiovascular disease, but additional long-term studies are needed to prove this. It is necessary to sensitize patients and doctors to the problem of AAS abuse in society, because this issue can become a significant risk factor for cardiovascular diseases in near future. 
546 |a EN 
546 |a ES 
546 |a PL 
546 |a RU 
546 |a UK 
690 |a anabolic-androgenic steroids 
690 |a cardiovascular diseases 
690 |a sport 
690 |a addiction 
690 |a Education 
690 |a L 
690 |a Sports 
690 |a GV557-1198.995 
690 |a Medicine 
690 |a R 
655 7 |a article  |2 local 
786 0 |n Journal of Education, Health and Sport, Vol 45, Iss 1 (2023) 
787 0 |n https://apcz.umk.pl/JEHS/article/view/45361 
787 0 |n https://doaj.org/toc/2391-8306 
856 4 1 |u https://doaj.org/article/da2bc3b05828490d9ae179d9ba6eeec1  |z Connect to this object online.